ImageneBio IMA
NASDAQ IMA
$4.08 -0.01 (-0.12%)
As of: Oct 22, 2026 · 11:45 AM EDT

ImageneBio (IMA) Total Debt (2023 - 2024)

Updated

ImageneBio (IMA) recorded Total Debt of $8.56 million in Q4 2024, up 801.2% from $950,000 a year earlier.

Analysis

ImageneBio (IMA) Total Debt (2023 - 2024) Analysis & Trends

  • Across earlier years, Total Debt came in at $950,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn 49.04 Bn
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn 70.82 Bn
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn 63.19 Bn
10 ImageneBio 34.79 Mn -452.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 8.56 Mn
Dec 31, 2023 950,000.00
Sep 30, 2023 852,000.00
API Access

ImageneBio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IMA&period=max&api_key=YOUR_API_KEY